Venous thrombosis. A potentially serious complication, thrombosis refers to the formation of blood clots in the veins. Severe inflammation. Pain after the procedure lasting several hours or days.
perforation or bleeding of the esophagus and lung problems, such as aspiration pneumonia. Long-term sclerotherapy can also damage the esophagus
Sclerotherapy for esophageal varices has a 20-40% incidence of complications and a 1-2% mortality rate. The procedure controls acute bleeding in about 90% of patients
the patient will be observed for signs of blood loss, lung complications, fever, a perforated esophagus, or other complications. Vital signs are monitored, and the intravenous line maintained.
Sclerotherapy is a treatment of injecting a solution to harden the veins.
Hemorrhage in the brain is a possible complication, as is infection.
there were 616,879 sclerotherapy procedures performed in the United States in 2001; 97% were performed on women and 3% were done on men
sclerotherapy
In most hospitals, sclerotherapy for esophageal varices is the treatment of choice to stop esophageal bleeding during acute episodes, and to prevent further incidences of bleeding.
what to do for nystatin ingestion
As with any invasive surgical procedure, hemorrhage, infarction, stroke, heart attack, and infection are all possible complications of heart valve repair.
Sclerotherapy for esophageal varices has a 20-40% incidence of complications.transient chest pain.difficulty swallowing.fever.allergic reactions.Infection.bleeding of the esophagus.lung problems.protein intoxication.1-2% percent mortality rate.
Sclerotherapy for esophageal varices involves injecting a sclerosing agent into the varices to induce scarring and collapse them. This helps stop bleeding and reduce the risk of complications such as rupture. It is commonly used as a treatment option for managing and preventing bleeding episodes in patients with esophageal varices.